articleD&I: What health companies should be doing post-pandemic28 October 2021 | By Luke Robinson (Included)Luke Robinson from Included highlights the impact of diversity and inclusion issues in the pharma industry, reflecting on the benefits to be gained from fundamental engagement with them.